ADC Therapeutics S.A. (ADCT)
NYSE · Healthcare
ADC Therapeutics S.A. Shares Outstanding 2022–2025
ADC Therapeutics S.A. annual/quarterly shares outstanding history and growth rate from 2022 to 2026. Shares outstanding refers to a company's stock currently held by all its shareholders, including institutional investors and company insiders.
- ADC Therapeutics S.A. shares outstanding for the quarter ending March 31, 2026 was 0.15 B shs, a 43.79% increase year-over-year.
- ADC Therapeutics S.A. annual shares outstanding for 2025 was 0.13 B shs, a 30.78% increase from 2024.
- ADC Therapeutics S.A. annual shares outstanding for 2024 was 0.10 B shs, a 18.91% increase from 2023.
- ADC Therapeutics S.A. annual shares outstanding for 2023 was 0.08 B shs, a 4.55% increase from 2022.
- ADC Therapeutics S.A. annual shares outstanding for 2022 was 0.08 B shs.
Shares Outstanding
ANNUAL · B SHS
QUARTERLY · B SHS
YEAR-OVER-YEAR GROWTH · %
ADC Therapeutics S.A. Shares Outstanding — FAQ
ADC Therapeutics S.A. (ADCT) shares outstanding over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is ADC Therapeutics S.A.'s shares outstanding?
ADC Therapeutics S.A. (ADCT) reported shares outstanding of 0.13B shares for fiscal 2025.
Where can I see ADCT's shares outstanding history?
The chart and table above show ADC Therapeutics S.A.'s shares outstanding by year and by quarter, including the growth rate.